Accelerate Diagnostics Inc (AXDX) 22.86 $AXDX
Commit To Buy Accelerate Diagnostics At $17.50, Earn 21.6% Annualized Using Options
at The Street - Wed Feb 04, 10:36AM CST
Investors considering a purchase of Accelerate Diagnostics Inc shares, but cautious about paying the going market price of $22.13/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting...
AXDX: 22.86 (-0.33)
Meridian Bioscience: In-line Earnings, Revenue Beat in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 26, 8:10AM CST
Diagnostic test-kit maker Meridian Bioscience, Inc. (VIVO) reported first-quarter fiscal 2015 (ended Dec 31, 2014) EPS of 19 cents, up 6% on a year-over-year basis and inline with the Zacks Consensus Estimate
VIVO: 19.15 (+0.16), AXDX: 22.86 (-0.33), IDXX: 159.08 (+1.72), VRML: 2.08 (+0.12)
Nasdaq stocks posting largest percentage decreases
AP - Thu Jan 15, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
CENX: 23.10 (-0.17), VBFC: 17.00 (-0.81), PODD: 32.00 (-0.07), FLML: 14.15 (+0.15), AXDX: 22.86 (-0.33), LPCN: 5.91 (+0.40), PEIX: 9.82 (+0.15), MTEX: 23.89 (+0.69), DWCH: 6.26 (-0.18)
5 Stocks With Big Insider Buying: VIVUS and More
at The Street - Thu Jan 08, 11:07AM CST
Insiders usually buy their own shares for one reason: They think the stock is a bargain and has tremendous upside.
CLUB: 6.94 (+0.10), AXDX: 22.86 (-0.33), VVUS: 2.68 (+0.13), GPRE: 25.50 (-0.56), LTS: 3.92 (-0.02)
Accelerate Diagnostics to Present at the 33rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Wed Jan 07, 4:30AM CST
Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, announced today that Lawrence Mehren, Chief Executive Officer, is scheduled to present a corporate update at the 33 Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 13th at 3:30PM PT.
AXDX: 22.86 (-0.33), JPM: 59.67 (+0.10)
InsiderInsights.com Daily Round Up 1/5/15: LTS, AXDX, VEEV, CAS
InsiderInsights - at Seeking Alpha - Tue Jan 06, 4:05AM CST
STFC: 23.46 (+0.15), LBTYK: 50.78 (+2.40), CASM: 1.36 (-0.01), IP: 57.31 (+0.12), VVUS: 2.68 (+0.13), STRN: 5.33 (-0.04), LTS: 3.92 (-0.02), WDC: 107.61 (+0.42), VEEV: 30.12 (+0.17), HLT: 28.57 (+0.13), LNKD: 269.00 (+1.83), AXDX: 22.86 (-0.33), ENSV: 2.23 (+0.04), CAS: 6.14 (-0.01), GPRE: 25.50 (-0.56), BLMN: 24.45 (-0.16), JGW: 10.70 (-0.16), CRM: 62.85 (+1.59)
Accelerate Diagnostics Announces Research Collaboration With CDC Laboratory for Early Detection of Antibiotic-Resistant Biothreat Agents
GlobeNewswire - Mon Nov 03, 12:50PM CST
Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms, today announced that it has entered into a research collaboration with the Rapid Antimicrobial Susceptibility Testing Laboratory at the U.S. Centers for Disease Control and Prevention (CDC) to develop tests for the rapid analysis of antibiotic-resistant biothreat agents based on Accelerate's high-speed identification and antibiotic susceptibility testing platform.
AXDX: 22.86 (-0.33)
Accelerate Diagnostics: Mistakenly Rewarded And Destined To Crash?
The Street Sweeper - Seeking Alpha - Tue Oct 14, 10:42AM CDT
Accelerate Diagnostics (NASDAQ: AXDX ) might need to credit a "false positive" for making its stock price look so much healthier these days. Mistaken by some as a promising Ebola play , AXDX has skyrocketed in value over the course of the...
AXDX: 22.86 (-0.33)
Trade-Ideas: Accelerate Diagnostics (AXDX) Is Today's Weak On High Relative Volume Stock
at The Street - Mon Oct 06, 9:02AM CDT
Trade-Ideas LLC identified Accelerate Diagnostics (AXDX) as a weak on high relative volume candidate
AXDX: 22.86 (-0.33)
3 Hot Stocks to Trade (or Not)
at The Street - Fri Oct 03, 2:22PM CDT
Here's how to trade some of the most-active stocks on the market right now.
AXDX: 22.86 (-0.33), PANW: 135.27 (+2.26), MBLY: 36.26 (-0.15)
Accelerate Diagnostics Supports Drug Stewardship and Early Detection in the President's Initiative to Combat Antibiotic-Resistant Bacteria
GlobeNewswire - Thu Sep 25, 1:35PM CDT
Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms, today commended the Obama Administration's actions to combat antibiotic-resistant bacteria, and underscored two areas of critical importance.
AXDX: 22.86 (-0.33)
Matthew Strobeck of Accelerate Diagnostics, Inc. (AXDX)-Nasdaq bought Shares of AXDX
M2 - Thu Aug 07, 11:11AM CDT
Reported by InsiderCow.com at 2014-08-06 12:48:50 ET
AXDX: 22.86 (-0.33)
5 Stocks Insiders Love Right Now
at The Street - Wed Jul 23, 12:03PM CDT
Insiders at these companies have been scooping up shares of their own stock lately.
AA: 15.81 (+0.16), AXDX: 22.86 (-0.33), BCRH: 18.08 (+0.46), CFX: 52.02 (+3.84), SYRG: 11.87 (-0.12)
Multiple Insiders of Accelerate Diagnostics, Inc. (AXDX)-NasdaqCM bought Shares of AXDX
M2 - Mon Jul 21, 8:37AM CDT
Reported by InsiderCow.com at 2014-07-18 10:04:13 ET
AXDX: 22.86 (-0.33)
Commit To Buy Accelerate Diagnostics At $17.50, Earn 21.6% Annualized Using Options
at The Street - Wed Feb 04, 10:36AM CST
Investors considering a purchase of Accelerate Diagnostics Inc shares, but cautious about paying the going market price of $22.13/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting...
AXDX: 22.86 (-0.33)
Meridian Bioscience: In-line Earnings, Revenue Beat in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 26, 8:10AM CST
Diagnostic test-kit maker Meridian Bioscience, Inc. (VIVO) reported first-quarter fiscal 2015 (ended Dec 31, 2014) EPS of 19 cents, up 6% on a year-over-year basis and inline with the Zacks Consensus Estimate
VIVO: 19.15 (+0.16), AXDX: 22.86 (-0.33), IDXX: 159.08 (+1.72), VRML: 2.08 (+0.12)
Nasdaq stocks posting largest percentage decreases
AP - Thu Jan 15, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
CENX: 23.10 (-0.17), VBFC: 17.00 (-0.81), PODD: 32.00 (-0.07), FLML: 14.15 (+0.15), AXDX: 22.86 (-0.33), LPCN: 5.91 (+0.40), PEIX: 9.82 (+0.15), MTEX: 23.89 (+0.69), DWCH: 6.26 (-0.18)
5 Stocks With Big Insider Buying: VIVUS and More
at The Street - Thu Jan 08, 11:07AM CST
Insiders usually buy their own shares for one reason: They think the stock is a bargain and has tremendous upside.
CLUB: 6.94 (+0.10), AXDX: 22.86 (-0.33), VVUS: 2.68 (+0.13), GPRE: 25.50 (-0.56), LTS: 3.92 (-0.02)
Accelerate Diagnostics to Present at the 33rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Wed Jan 07, 4:30AM CST
Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, announced today that Lawrence Mehren, Chief Executive Officer, is scheduled to present a corporate update at the 33 Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 13th at 3:30PM PT.
AXDX: 22.86 (-0.33), JPM: 59.67 (+0.10)
InsiderInsights.com Daily Round Up 1/5/15: LTS, AXDX, VEEV, CAS
InsiderInsights - at Seeking Alpha - Tue Jan 06, 4:05AM CST
STFC: 23.46 (+0.15), LBTYK: 50.78 (+2.40), CASM: 1.36 (-0.01), IP: 57.31 (+0.12), VVUS: 2.68 (+0.13), STRN: 5.33 (-0.04), LTS: 3.92 (-0.02), WDC: 107.61 (+0.42), VEEV: 30.12 (+0.17), HLT: 28.57 (+0.13), LNKD: 269.00 (+1.83), AXDX: 22.86 (-0.33), ENSV: 2.23 (+0.04), CAS: 6.14 (-0.01), GPRE: 25.50 (-0.56), BLMN: 24.45 (-0.16), JGW: 10.70 (-0.16), CRM: 62.85 (+1.59)
Accelerate Diagnostics Announces Research Collaboration With CDC Laboratory for Early Detection of Antibiotic-Resistant Biothreat Agents
GlobeNewswire - Mon Nov 03, 12:50PM CST
Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms, today announced that it has entered into a research collaboration with the Rapid Antimicrobial Susceptibility Testing Laboratory at the U.S. Centers for Disease Control and Prevention (CDC) to develop tests for the rapid analysis of antibiotic-resistant biothreat agents based on Accelerate's high-speed identification and antibiotic susceptibility testing platform.
AXDX: 22.86 (-0.33)
Accelerate Diagnostics: Mistakenly Rewarded And Destined To Crash?
The Street Sweeper - Seeking Alpha - Tue Oct 14, 10:42AM CDT
Accelerate Diagnostics (NASDAQ: AXDX ) might need to credit a "false positive" for making its stock price look so much healthier these days. Mistaken by some as a promising Ebola play , AXDX has skyrocketed in value over the course of the...
AXDX: 22.86 (-0.33)
Trade-Ideas: Accelerate Diagnostics (AXDX) Is Today's Weak On High Relative Volume Stock
at The Street - Mon Oct 06, 9:02AM CDT
Trade-Ideas LLC identified Accelerate Diagnostics (AXDX) as a weak on high relative volume candidate
AXDX: 22.86 (-0.33)
3 Hot Stocks to Trade (or Not)
at The Street - Fri Oct 03, 2:22PM CDT
Here's how to trade some of the most-active stocks on the market right now.
AXDX: 22.86 (-0.33), PANW: 135.27 (+2.26), MBLY: 36.26 (-0.15)
Accelerate Diagnostics Supports Drug Stewardship and Early Detection in the President's Initiative to Combat Antibiotic-Resistant Bacteria
GlobeNewswire - Thu Sep 25, 1:35PM CDT
Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms, today commended the Obama Administration's actions to combat antibiotic-resistant bacteria, and underscored two areas of critical importance.
AXDX: 22.86 (-0.33)
Matthew Strobeck of Accelerate Diagnostics, Inc. (AXDX)-Nasdaq bought Shares of AXDX
M2 - Thu Aug 07, 11:11AM CDT
Reported by InsiderCow.com at 2014-08-06 12:48:50 ET
AXDX: 22.86 (-0.33)
5 Stocks Insiders Love Right Now
at The Street - Wed Jul 23, 12:03PM CDT
Insiders at these companies have been scooping up shares of their own stock lately.
AA: 15.81 (+0.16), AXDX: 22.86 (-0.33), BCRH: 18.08 (+0.46), CFX: 52.02 (+3.84), SYRG: 11.87 (-0.12)
Multiple Insiders of Accelerate Diagnostics, Inc. (AXDX)-NasdaqCM bought Shares of AXDX
M2 - Mon Jul 21, 8:37AM CDT
Reported by InsiderCow.com at 2014-07-18 10:04:13 ET
AXDX: 22.86 (-0.33)
